IOBT – io biotech, inc. (US:NASDAQ)

News

IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications [Yahoo! Finance]
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Wall Street Zen
IO Biotech Announces Participation in Upcoming December Investor Conferences [Yahoo! Finance]
IO Biotech Announces Participation in Upcoming December Investor Conferences
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com